FDA approves the first generic version of EpiPen
(By Ike Swetlitz for STAT) WASHINGTON — The Food and Drug Administration approved the first-ever generic version of EpiPen Thursday — a
Read More
Emerging Health Issues
Scientists Race To Improve ‘Living Drugs’ To Fight Cancer
(By Rob Stein for NPR) Aaron Reid is lying in a hospital bed at the National Institutes of Health when
Read MoreAdvances In Treating Hep C Lead To New Option For Transplant Patients
(By Julie Appleby for Kaiser Health News) After her kidneys failed from the same illness that took the lives of
Read MoreClinicians Who Learn Of A Patient’s Opioid Death Modestly Cut Back On Prescriptions
(By Anna Gorman for Kaiser Health News) Physicians and other medical providers modestly reduced the volume of opioids they prescribed
Read MoreAs Opioid Crisis Rages, Some Trade ‘Tough Love’ For Empathy
(By Martha Bebinger, WBUR for Kaiser Health News) It was Bea Duncan who answered the phone at 2 a.m. on
Read MoreCan a phone app’s warnings to avoid risky friends and places prevent opioid addiction relapses?
(By Orly Nadell Farber for STAT) You’re in recovery from opioid addiction, and your walk to work takes you down
Read MoreFDA will broaden how it evaluates new addiction treatment drugs
(By Lev Facher for STAT) The Food and Drug Administration on Monday announced a shift in the way it evaluates drugs
Read MoreHow Rival Opioid Makers Sought To Cash In On Alarm Over OxyContin’s Dangers
(By Fred Schulte for Kaiser Health News) As Purdue Pharma faced mounting criticism over deaths linked to OxyContin, rival drugmakers
Read MorePatients With Chronic Pain Feel Caught In An Opioid-Prescribing Debate
(By Will Stone for Kaiser Health News) It started with a rolled ankle during a routine Army training exercise. Shannon
Read MoreNew report suggests rebates are not to blame for increasing drug prices
A new report by the consulting company Milliman prepared for America’s Health Insurance Plans (AHIP), suggest that drug rebates are
Read More